1003751-09-4 Usage
Uses
Used in Pharmaceutical Industry:
Ketoprofen is used as an analgesic and anti-inflammatory agent for the treatment of conditions such as arthritis, menstrual cramps, muscle aches, and dental pain. Its application is aimed at providing relief from pain and reducing inflammation, thereby improving the quality of life for patients suffering from these conditions.
Used in Medical Treatment:
As a nonsteroidal anti-inflammatory drug, ketoprofen is utilized in medical treatment to manage pain and inflammation associated with various ailments. Its use is justified by its ability to inhibit prostaglandin production, which are key mediators of pain and inflammation in the body.
Used in Pain Management:
Ketoprofen is employed as a pain management tool, particularly for individuals experiencing moderate to severe pain. Its application in this context is due to its effectiveness in reducing pain and inflammation, allowing for improved comfort and mobility.
Used in Inflammation Reduction:
Ketoprofen is used to reduce inflammation in various parts of the body. Its application in this area is aimed at decreasing the swelling, redness, and heat associated with inflammation, which can be detrimental to one's health and well-being.
Check Digit Verification of cas no
The CAS Registry Mumber 1003751-09-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,3,7,5 and 1 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1003751-09:
(9*1)+(8*0)+(7*0)+(6*3)+(5*7)+(4*5)+(3*1)+(2*0)+(1*9)=94
94 % 10 = 4
So 1003751-09-4 is a valid CAS Registry Number.
1003751-09-4Relevant articles and documents
Asymmetric [3 + 3] Annulation of Copper-Allenylidenes with Pyrazolones: Synthesis of Chiral 1,4-Dihydropyrano[2,3- c]pyrazoles
Jiang, Feng,Feng, Xinping,Wang, Rou,Gao, Xing,Jia, Hao,Xiao, Yumei,Zhang, Cheng,Guo, Hongchao
supporting information, p. 5278 - 5281 (2018/09/13)
The copper-catalyzed asymmetric [3 + 3] annulation of ethynyl benzoxazinanones with pyrazolones has been achieved, providing simple access to 1,4-dihydropyrano[2,3-c]pyrazole derivatives in moderate to excellent yields with excellent enantioselectivities (up to 99% ee). Compared with previous annulation reactions of copper-allenylidenes from ethynyl benzoxazinanones, the current reaction fused the three carbon atoms of the propargyl moiety into a heterocyclic framework.
